Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Connective Tissue Disorder”

5,492 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,492 results

Not applicableUnknownNCT06119763
What this trial is testing

AntiDFS70 Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT05665985
What this trial is testing

Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Universitas Sebelas Maret 30
Not applicableUnknownNCT04275206
What this trial is testing

The Anti-inflammatory Effects of Harkány Medicinal Water

Who this might be right for
Rheumatoid ArthritisPsoriasis
University of Pecs 350
Testing effectiveness (Phase 2)Ended earlyNCT00634933
What this trial is testing

Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 222
Not applicableLooking for participantsNCT04265144
What this trial is testing

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Who this might be right for
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux 500
Not applicableNot Yet RecruitingNCT06588192
What this trial is testing

Renal Survival in Patients with Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 97
Testing effectiveness (Phase 2)Ended earlyNCT01569152
What this trial is testing

Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)

Who this might be right for
Rheumatoid Arthritis (RA)
Merck Sharp & Dohme LLC 82
Large-scale testing (Phase 3)Study completedNCT01126541
What this trial is testing

SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 224
Not applicableLooking for participantsNCT06417502
What this trial is testing

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Who this might be right for
Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital 20,000
Not applicableEnrolling By InvitationNCT03755245
What this trial is testing

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

Who this might be right for
Healthy SubjectsRheumatoid ArthritisVasculitis+1 more
Turku University Hospital 26
Post-approval studies (Phase 4)Study completedNCT00792233
What this trial is testing

Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA

Who this might be right for
Juvenile Idiopathic Arthritis
Children's Hospital Medical Center, Cincinnati 137
Testing effectiveness (Phase 2)WithdrawnNCT02795299
What this trial is testing

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bird Rock Bio, Inc.
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Not applicableUnknownNCT03636763
What this trial is testing

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Who this might be right for
Bullous Pemphigoid
Assistance Publique Hopitaux De Marseille 183
Testing effectiveness (Phase 2)Study completedNCT02633163
What this trial is testing

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

Who this might be right for
Systemic Lupus Erythematosus
Medical University of South Carolina 81
Post-approval studies (Phase 4)Study completedNCT02374021
What this trial is testing

Treatments Against RA and Effect on FDG-PET/CT

Who this might be right for
Arthritis, Rheumatoid
Brigham and Women's Hospital 159
Not applicableUnknownNCT04550884
What this trial is testing

Neuropathic Foot and Ankle in Rheumatoid Arthritis : Ultrasound and Nerve Conduction Study

Who this might be right for
Rheumatoid Arthritis
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT01441076
What this trial is testing

Anakinra for Behcet s Disease

Who this might be right for
Autoimmune Connective Tissue DisorderImmune System Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Not applicableLooking for participantsNCT06108934
What this trial is testing

A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.

Who this might be right for
Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))
Stryker Australia Pty Ltd. 313
Load More Results